Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Lessons From Lockdown: Perspectives on Hepatitis C Care in the US and Australia—Audio Recap

Listen to insights from 2 expert faculty in this dialogue on lessons learned in the care of patients with HCV infection during the COVID-19 pandemic, including patients who inject drugs.
Gregory Dore, MBBS, PhD, FRACP, MPH
Stacey Trooskin, MD, PhD, MPH
Released: November 10, 2021

In this episode, Gregory Dore, MBBS, PhD, FRACP, MPH, and Stacey Trooskin, MD, PhD, MPH, share lessons learned in the care of patients with HCV infection during the COVID-19 pandemic, including:

  • Telehealth
  • Treatment of PWID
  • TEMPO pilot study
  • MINMON study

Information on this Educational Activity

Faculty

Gregory Dore, MBBS, PhD, FRACP, MPH

Professor, Head
Viral Hepatitis Clinical Research Program
Kirby Institute
University of New South Wales
Professor
Infectious Diseases Physician
St Vincent's Hospital
Sydney, Australia

Greg Dore, MBBS, PhD, FRACP, MPH, has no relevant conflicts of interest to report.
Stacey Trooskin, MD, PhD, MPH

Chief Medical Officer
Philadelphia FIGHT Community Health Centers
Faculty
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Stacey Trooskin, MD, PhD, MPH, has disclosed that she has received funds for research support and consulting fees from Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grants provided by:
AbbVie
Gilead Sciences, Inc.

Related Content

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis

person default Sherry Tierney Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Clinical Care Options (CCO) audio: patient insights on universal HCV screening and the ease and benefits of curative treatment

Norah Terrault Headshot Norah Terrault, MD, MPH Released: May 3, 2022

Dr Dominique Braun discusses HCV in HIV-positive men who have sex with men (MSM) in the Swiss HIV Cohort Study, from Clinical Care Options (CCO)

Dominique Laurent Braun, MD Released: April 27, 2022

Clinical Care Options (CCO) audio: patient insights on overcoming barriers to HCV care for people with a history of injection drug use

Oluwaseun Falade-Nwulia, MBBS, MPH Released: April 20, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings